DPP4 was also investigated in relation to the deposition and accumulation of fat in ectopic sites, in particular in the liver, a condition known as nonalcoholic fatty liver disease (NAFLD) and, in its more severe form, steatohepatitis (NASH). This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatotic liver disease.